Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells K. Y. TsangM. D. FinchJ. Schlom Original articles Pages: 9 - 16
Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells Yoshinori TsuchiyaMichiko MatsutaniMotoyuki Yajima Original articles Pages: 17 - 23
In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chain Odile Rostaing-CapaillonPierre Casellas Original articles Pages: 24 - 30
Human lymphokine-activated killer (LAK) cells: III. Effect ofl-phenylalanine methyl ester on LAK cell activation from human peripheral blood mononuclear cells: Possible protease involvement of monocytes, natural killer cells and LAK cells Kam H. Leung Original articles Pages: 31 - 36
Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site Rita PellegriniFilippo CentisMaria I. Colnaghi Original articles Pages: 37 - 42
Immunotherapy of B lymphoma by anti-idiotype antibodies: Characterization of variant tumour cells appearing a long time after the initial tumour inoculation Mahmoud TayaJoseph Haimovich Original articles Pages: 43 - 48
Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity James S. EconomouMary HobanDonald L. Morton Original articles Pages: 49 - 52
Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: The pattern of in vitro reactivity predicts the in vivo effect on different tumours Monica RodolfoCinzia BassiGiorgio Parmiani Original articles Pages: 53 - 62
Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus Eva NagyIstvan BercziAlec H. Sehon Original articles Pages: 63 - 69